Alena Gros

10PUBLICATIONS
112CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 26, 2026
Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity.

Ander de Blas, Massimo Andreatta, Asier Antoñana-Vildosola

|May 19, 2025
A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

Maria Alsina, Guillermo Villacampa, Carlos de Andrea

|Jan 24, 2024
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez

|Mar 08, 2023
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy.

Cristina Puig-Saus, Barbara Sennino, Songming Peng

|Feb 07, 2023
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.

Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero

|Oct 27, 2022
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity.

Ines Marin, Olga Boix, Andrea Garcia-Garijo

Pageof 2